Mineralys Therapeutics

Mineralys Therapeutics

Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that we are developing for cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease.

Mineralys is a fully remote company.

For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn.

Departments (8)
Offices (1)
1
open positions
1
hiring across
0
last 24 hours
0
remote listings
1  positions
Mineralys Therapeutics
Digital Center of Excellence Project Manager
Mineralys Therapeutics
US Remote Program Management 1w ago

Pick a job to read the details

Tap any role on the left — its description and apply link will open here.